State Street’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$227M Buy
12,297,256
+15,513
+0.1% +$286K 0.01% 819
2025
Q1
$215M Buy
12,281,743
+93,891
+0.8% +$1.64M 0.01% 853
2024
Q4
$211M Buy
12,187,852
+497,452
+4% +$8.62M 0.01% 904
2024
Q3
$218M Sell
11,690,400
-123,492
-1% -$2.3M 0.01% 870
2024
Q2
$182M Buy
11,813,892
+104,576
+0.9% +$1.61M 0.01% 911
2024
Q1
$173M Sell
11,709,316
-789,284
-6% -$11.7M 0.01% 956
2023
Q4
$178M Buy
12,498,600
+56,525
+0.5% +$807K 0.01% 917
2023
Q3
$173M Buy
12,442,075
+128,401
+1% +$1.79M 0.01% 848
2023
Q2
$145M Sell
12,313,674
-150,668
-1% -$1.77M 0.01% 985
2023
Q1
$143M Sell
12,464,342
-14,740
-0.1% -$170K 0.01% 968
2022
Q4
$155M Buy
12,479,082
+273,193
+2% +$3.4M 0.01% 888
2022
Q3
$160M Buy
12,205,889
+81,240
+0.7% +$1.07M 0.01% 825
2022
Q2
$169M Buy
12,124,649
+88,883
+0.7% +$1.24M 0.01% 825
2022
Q1
$179M Buy
12,035,766
+1,840,939
+18% +$27.4M 0.01% 906
2021
Q4
$138M Buy
10,194,827
+1,006,444
+11% +$13.6M 0.01% 1056
2021
Q3
$135M Buy
9,188,383
+499,491
+6% +$7.35M 0.01% 1050
2021
Q2
$158M Buy
8,688,892
+285,797
+3% +$5.2M 0.01% 985
2021
Q1
$146M Sell
8,403,095
-144,728
-2% -$2.51M 0.01% 963
2020
Q4
$148M Buy
8,547,823
+7,822
+0.1% +$136K 0.01% 889
2020
Q3
$118M Sell
8,540,001
-710,076
-8% -$9.79M 0.01% 884
2020
Q2
$133M Sell
9,250,077
-154,420
-2% -$2.23M 0.01% 810
2020
Q1
$103M Buy
9,404,497
+1,477,687
+19% +$16.1M 0.01% 840
2019
Q4
$169M Sell
7,926,810
-545,183
-6% -$11.6M 0.01% 765
2019
Q3
$195M Buy
8,471,993
+320,001
+4% +$7.35M 0.01% 693
2019
Q2
$161M Buy
8,151,992
+704,543
+9% +$13.9M 0.01% 767
2019
Q1
$145M Buy
7,447,449
+1,253,289
+20% +$24.4M 0.01% 800
2018
Q4
$102M Sell
6,194,160
-369,336
-6% -$6.09M 0.01% 896
2018
Q3
$152M Buy
6,563,496
+131,375
+2% +$3.04M 0.01% 829
2018
Q2
$140M Sell
6,432,121
-173,284
-3% -$3.77M 0.01% 839
2018
Q1
$117M Sell
6,605,405
-45,130
-0.7% -$797K 0.01% 925
2017
Q4
$125M Buy
6,650,535
+654,153
+11% +$12.3M 0.01% 906
2017
Q3
$132M Buy
5,996,382
+4,220,394
+238% +$92.6M 0.01% 836
2017
Q2
$42.8M Buy
1,775,988
+65,393
+4% +$1.58M ﹤0.01% 1456
2017
Q1
$47.8M Buy
1,710,595
+137,778
+9% +$3.85M ﹤0.01% 1354
2016
Q4
$38.4M Buy
1,572,817
+167,688
+12% +$4.09M ﹤0.01% 1428
2016
Q3
$35.4M Buy
1,405,129
+57,626
+4% +$1.45M ﹤0.01% 1409
2016
Q2
$27.8M Buy
1,347,503
+32,672
+2% +$674K ﹤0.01% 1523
2016
Q1
$26.4M Buy
1,314,831
+48,078
+4% +$966K ﹤0.01% 1526
2015
Q4
$25.6M Buy
1,266,753
+5,268
+0.4% +$107K ﹤0.01% 1536
2015
Q3
$29.2M Buy
1,261,485
+32,747
+3% +$759K ﹤0.01% 1497
2015
Q2
$31.6M Buy
1,228,738
+68,512
+6% +$1.76M ﹤0.01% 1559
2015
Q1
$38.5M Buy
1,160,226
+168,528
+17% +$5.59M ﹤0.01% 1389
2014
Q4
$30.1M Buy
991,698
+86,641
+10% +$2.63M ﹤0.01% 1506
2014
Q3
$22M Sell
905,057
-25,780
-3% -$627K ﹤0.01% 1670
2014
Q2
$26.7M Buy
930,837
+150,371
+19% +$4.32M ﹤0.01% 1616
2014
Q1
$21.8M Buy
780,466
+19,650
+3% +$548K ﹤0.01% 1720
2013
Q4
$19.9M Buy
760,816
+6,201
+0.8% +$162K ﹤0.01% 1757
2013
Q3
$17.4M Sell
754,615
-2,221
-0.3% -$51.1K ﹤0.01% 1792
2013
Q2
$19.8M Buy
+756,836
New +$19.8M ﹤0.01% 1638